MAGNETOM World
MAGNETOM World
  1. MAGNETOM World
  2. Clinical Corner
  3. Clinical Talks

Clinical Talks

Experience the talks we have captured during various Workshops and Events.
Preview Clinical Talk Adrienne Campbell-Washburn

First Experiences with BIOGRAPH One PET/MR

 2025-11-10

Kirsten Korsholm, MD, PhD. (Rigshospitalet, Copenhagen, Denmark) 
EANM 2025, Barcelona, Spain

Dementia Imaging Update: Role of the Radiologist in the Era of Disease-Modifying Therapies

 2025-11-10

Ana M. Franceschi, MD, PhD
(Lenox Hill Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA)


ECR Lunch Symposium 2025
Vienna, Austra

Preview Clinical Talk Adrienne Campbell-Washburn

First Impressions of the BIOGRAPH One PET/MRI at Rigshospitalet

 2025-11-10

Thomas Lund Andersen, PhD, MPE
(Rigshospitalet, Copenhagen, Denmark)


ESHI CHILI 2025


MAGNETOM World Webinar

 2025-10-22

October 2025

Opportunities for Functional and Vascular Imaging at 7T

 2025-08-04

Saskia Bollmann, Ph.D. (The University of Queensland, Brisbane, Australia)

OHBM 2025, Brisbane, Australia


The Australian Epilepsy Project: Transforming how we Utilize MRI in Epilepsy

 2025-08-04

David N. Vaughan, M.D., Ph.D. (The Florey Institute of Neuroscience & Mental Health, Melbourne, Australia)

OHBM 2025, Brisbane, Australia


MR-Spectroscopy at 7T

 2025-07-29

Johannes Slotboom, Ph.D. (University Hospital Bern, Switzerland)

UHF User Meeting, Frankfurt, Germany


Next Gen 7T and Impulse Gradient

 2025-07-29

David A. Feinberg, Ph.D.
(University of California, Berkeley, CA, USA)

UHF User Meeting, Frankfurt, Germany

The Path Ahead: Clinical Neuro UHF

 2025-07-29

Lawrence L. Wald, Ph.D. (A.A. Martinos Center for Biomedical Imaging, Boston, MA, USA)

UHF User Meeting, Frankfurt, Germany


The Path Ahead in UHF Research

 2025-07-29

Kamil Ugurbil, Ph.D. (University of Minnesota, CMMR, Minneapolis, MN, USA)

UHF User Meeting, Frankfurt, Germany


Metabolic Imaging at UHF 7T MRI

 2025-07-28

Daniel Paech, M.D., Ph.D., M.Sc. (Mass General Brigham, Boston, MA, USA) 

UHF User Meeting, Frankfurt, Germany

Quantitative Sodium (23Na) and Potassium (39K) MRI at 7T

 2025-07-28

Armin M. Nagel, Ph.D. (University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU) Germany) 

UHF User Meeting, Frankfurt, Germany

Clinical 7T at Cleveland Clinic

 2025-07-24

Stephen Jones, M.D., Ph.D. (Neuroradiology, Cleveland Clinic, Cleveland, OH, USA) 

UHF User Meeting, Frankfurt, Germany

Advancements in 7T Neurovascular Imaging of Cerebral Small Vessel Disease

 2025-07-24

Zihao Zhang, Ph.D. (Institute of Biophysics, Chinese Academy of Sciences, Beijing, China) 

UHF User Meeting, Frankfurt, Germany

Clinical Neuro Applications at 7T

 2025-07-23

Xin Lou, M.D. (PLA General Hospital, Beijing, China) 

UHF User Meeting, Frankfurt, Germany

The herein illustrated statements made by Siemens’ customers and physicians are based on their own and discrete opinion. The speaker is responsible for obtaining permission to use any previously published figures or tables. The speaker is also responsible for obtaining permission to reproduce any photograph showing recognizable persons.
The statements by Siemens’ customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist there can be no guarantee that other customers will achieve the same results.
Some products/features (here mentioned) are not necessarily commercially available in all countries. Due to regulatory reasons their availability cannot be guaranteed. Please contact your local Siemens organization for further details.
MAGNETOM 7T and 9.4T are ongoing research. All data shown are acquired using non-commercial systems under institutional review board permission. Siemens does not intend to commercialize the systems. MAGNETOM Terra is currently under development and is not for sale in the US and in other countries. Its future availability cannot be ensured.
The MRI restrictions (if any) of the metal implant must be considered prior to patient undergoing MRI exam. MR imaging of patients with metallic implants brings specific risks. However, certain implants are approved by the governing regulatory bodies to be MR conditionally safe. For such implants, the previously mentioned warning may not be applicable. Please contact the implant manufacturer for the specific conditional information. The conditions for MR safety are the responsibility of the implant manufacturer, not of Siemens.
MR scanning has not been established as safe for imaging fetuses and infants less than two years of age. The responsible physician must evaluate the benefits of the MR examination compared to those of other imaging procedures.